Biogen lowers 2025 EPS guidance despite Q3 beats

4 hours ago 1

Even though its Q3 financial results beat on both lines, Biogen (BIIB) is cutting its full-year non-GAAP EPS forecast.
EPS for 2025 is now seen at $14.50-$15.00, down from $15.50-$16.00 prior. Biogen noted that the change is due to an expected approximately ($1.25) EPS impact in